Cancer Cells Gone Wild: Real Biology Exposed

In this episode, Jess welcomes Dr. Liz Marnik and Dr. Irini Hadjisavva to explore the multifaceted nature of inflammation and its impact on health. The scientists distinguish between beneficial and harmful inflammatory responses while addressing the challenges of accurately measu ...  Show more

In this episode, Jess and Sarah welcome Dr. Kate Wallis and Dr. Diana Montoya-Williams to explore the essential topic of health equity in scientific research. The scientists examine the critical importance of rigorous research design and the transformative role of community engag ...  Show more

This week, we continue our discussion of colorectal cancer, turning our attention to metastatic disease, specifically for cancers without targetable mutations. If you have not done already, we highly recommend you check out episode 104 for our GI oncology pharmacology discussi ...

This week, we are joined by Dr. Nina Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology Service, UT Southwestern Medical Center in Dallas, Texas, for a discussion about the role of radiation in colorectal cancer, with an emphasis on the role of radia ...

In a recent American Cancer Society publication, there are increasing data that rates of colorectal cancer are rising rapidly among people in their 20s, 30s and 40s. This has certainly caught the attention of the lay press, most recently in a widely circulated New York Times a ...

Human epidermal growth factor receptor 2 (HER2) is overexpressed in multiple cancers, including breast, gastric, colorectal, and epithelial ovarian cancers. However, this receptor's complexity doesn't stop there. It has multiple subdomains and various responses to drugs, and t ...